Riverton Place

Located in Seattle, WA, Riverton Place operates within the WA regulatory framework as a licensed addiction-treatment provider. The facility offers specific levels of care: Inpatient. Structural evaluation of this facility's clinical posture requires review of state licensing records, accreditation status, and payer-network contracts.

Care levels at Riverton Place

The facility's documented care levels are The facility offers specific levels of care: Inpatient. — each of which is appropriate for specific clinical presentations. Matching the level to the specific clinical need is the pre-admission work. Operational prerequisite for admission: documented clinical assessment establishing medical necessity for the specific level of care Riverton Place provides. The ASAM Criteria 4e framework is the benchmark standard for this assessment and is referenced in most major payer medical-necessity documents.

Insurance and payment

Payment and insurance specifics for Riverton Place are not fully documented in the SAMHSA registry — a direct admissions conversation is the reliable way to confirm what forms of payment are accepted and at what network-contract level. The operational prerequisite for admission is written documentation of: (a) network contract status; (b) prior authorization; (c) cost-sharing structure; (d) medical-necessity criteria applied. Absence of any of these four increases the probability of post-admission financial disagreement.

Specialty programming

The facility's documented specialty programming includes: Young adults, Adult men, Seniors or older adults. Specialty-program verification requires review of: (a) dedicated specialty-track programming hours per week; (b) specialty-credentialed clinical staffing (e.g., LCSW with trauma specialization, perinatal-nurse certification, adolescent-development training); (c) specialty-specific clinical assessment protocols; (d) specialty-specific outcome measurement. Marketing designation alone is insufficient for clinical confidence.

Before you call

Pre-admission due-diligence for Riverton Place: (1) ASAM 4e level-of-care documentation matching clinical assessment; (2) written Verification of Benefits specific to insurance product; (3) MAT policy documentation (particularly buprenorphine and methadone continuation protocols for opioid use disorder patients); (4) accreditation verification via CARF or Joint Commission provider-search tools; (5) state licensing status confirmed via WA behavioral-health regulator inspection records. If the clinical situation involves opioid use disorder, confirm explicitly whether Riverton Place offers medication-assisted treatment — buprenorphine, methadone, or naltrexone. Programs that do not are operating outside the current standard of care.